Sgd Pharma India Private Limited - Company Profile

It is a packaging private limited company based in Mahbubnagar, Telangana, India, established in 2009.
2009 Mahbubnagar, Telangana, India Active
Last Updated:
Access Report
About Sgd Pharma India Private Limited

Sgd Pharma India Private Limited, a active private limited company, was established on 13 November 2009 in Mahbubnagar, Telangana, India. Engaging in pharmaceutical packaging solutions within the manufacturing sector, it holds CIN: U26100TG2009PTC065810. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹212.00 Cr and a paid-up capital of ₹207.11 Cr.

Formerly known as Sgd Pharma India Limited, Cogent Glass Limited. It upholds a compliant status. Employing 572 professional, Its leadership includes Deepak Sood (Managing Director), Olivier Rousseau Jean Francois (Director), Philippe Henry Max Pourquery (Director). Past directors included Bodh Raj Sikri, Ashok Sudan, Iqbal Singh Sardar. It holds ₹445.58 Cr open charges and ₹109.88 Cr settled loans. Its latest AGM occurred on 20 May 2025, with the balance sheet filed on 31 December 2024. It is based at Vemula Village, Moosapet Mandal, Mahbubnagar District - 509380, Mahbubnagar, Telangana, 509380.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U26100TG2009PTC065810

  • Registration Number

    065810

  • Incorporation Date

    13 November 2009

  • Authorized Capital

    ₹212.00 Cr

  • Paid-Up Capital

    ₹207.11 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 212.00 Cr
  • Paid Up Capital ₹ 207.11 Cr
  • Company Age 16 Year, 3 Months
  • Last Filing with ROC 31 Dec 2024
  • Open Charges ₹ 445.58 Cr
  • Satisfied Charges ₹ 109.88 Cr
  • Revenue Growth **** 13.06%
  • Profit Growth **** -31.86%
  • Ebitda **** 33.20%
  • Net Worth 394.00%
  • Total Assets **** 22.11%
Company report

Sgd Pharma India Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Sgd Pharma India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Sgd Pharma India Private Limited?
Current Directors
Name Designation Appointment Date Status
Deepak Sood Managing Director 27 Aug 2024 Current
Olivier Rousseau Jean Francois Director 06 Oct 2022 Current
Philippe Henry Max Pourquery Director 24 Jun 2024 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 05 Aug 2015 Past
Pramod Abcsdd Director 08 Jun 2016 Past
Pramod Abcsdd Director 17 Nov 2021 Past
Pramod Abcsdd Director 08 Jun 2016 Past
Pramod Abcsdd Additional Director 27 Jul 2017 Past
Pramod Abcsdd Additional Director 27 Jul 2017 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sgd Pharma India.

Sgd Pharma India Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 13.06% increase. The company also saw a substantial fall in profitability, with a 31.86% decrease in profit. The company's net worth Soared by an impressive increase of 394%.

Sgd Pharma India revenue growth over time
Sgd Pharma India profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 13.06%
*******
*******
*******
*******
Revenue from Operations
*******
 25.27%
*******
*******
*******
*******
Total Assets
*******
 22.11%
*******
*******
*******
*******
Profit or Loss
*******
 -31.86%
*******
*******
*******
*******
Net Worth
*******
 394.00%
*******
*******
*******
*******
EBITDA
*******
 33.20%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sgd Pharma India?

In 2022, Sgd Pharma India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹4,455,800,000.00

Satisfied Charges

₹1,098,800,000.00

Charges Breakdown by Lending Institutions
  • Sbicap Trustee Company Limited : 370.17 Cr
  • State Bank Of India : 63.41 Cr
  • Others : 12.00 Cr
Latest Charge Details
Date Lender Amount Status
12 Aug 2025 Others ₹12.00 Cr Open
18 Mar 2024 Sbicap Trustee Company Limited ₹370.17 Cr Open
09 Nov 2012 State Bank Of India ₹63.41 Cr Open
24 Feb 2020 Others ₹0.60 M Satisfied
18 Feb 2012 Icici Bank Limited ₹30.00 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Sgd Pharma India?

Sgd Pharma India has a workforce of 572 employees as of May 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Sgd Pharma India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sgd Pharma India's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sgd Pharma India
Recent Activity within the Organization
  • Charges

    A charge with Others amounted to Rs. 12.00 Cr with Charge ID 101149982 was registered on 12 Aug 2025. was recorded as a recent event.

  • Annual General Meeting

    The activity Sgd Pharma India Private Limited last Annual general meeting of members was held on 20 May 2025 as per latest MCA records. was completed.

  • Balance Sheet

    The activity Sgd Pharma India Private Limited has filed its annual Financial statements for the year ended 31 Dec 2024 with Roc Hyderabad. was completed.

  • Director Appointment

    The activity Deepak Sood was appointed as a Managing Director was appointed as a Managing Director on 27 Aug 2024 & has been associated with this company since 1 year 5 months . was completed.

  • Director Appointment

    The activity Mukul Kumar was appointed as a CFO was appointed as a CFO on 25 Jul 2024 & has been associated with this company since 1 year 6 months . was completed.

  • Director Appointment

    The activity Philippe Henry Max Pourquery was appointed as a Director was appointed as a Director on 24 Jun 2024 & has been associated with this company since 1 year 7 months . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Sgd Pharma India Private Limited?

The CIN of Sgd Pharma India Private Limited is U26100TG2009PTC065810.

Where is Sgd Pharma India Private Limited headquartered?

Sgd Pharma India Private Limited is headquartered at Vemula Village, Moosapet Mandal, Mahbubnagar District - 509380, Mahbubnagar, Telangana, 509380.

When was Sgd Pharma India Private Limited incorporated?

Sgd Pharma India Private Limited was incorporated on 13 November 2009.

Who are the current directors of Sgd Pharma India Private Limited?

The current directors of Sgd Pharma India Private Limited are

What is the primary industry of Sgd Pharma India Private Limited?

The primary industry of Sgd Pharma India Private Limited is Manufacturing.

Is Sgd Pharma India Private Limited a listed company?

Sgd Pharma India Private Limited is unlisted.

What is the capital structure of Sgd Pharma India Private Limited?

The authorized capital of Sgd Pharma India Private Limited is ₹212.00 Cr, and the paid-up capital is ₹207.11 Cr.

What is the compliance status of Sgd Pharma India Private Limited?

The compliance status of Sgd Pharma India Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available